tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:ONC Stock Latest News

Buy Rating for Oncolytics Biotech Driven by Promising Pelareorep Data in Pancreatic and Colorectal Cancers
RatingsBuy Rating for Oncolytics Biotech Driven by Promising Pelareorep Data in Pancreatic and Colorectal Cancers
18h ago
ONCY
Oncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL Event
PremiumCompany Announcements
Oncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL Event
3d ago
6K
ONCY
Oncolytics announces highlights from KOL on pelareorep data
PremiumThe Fly
Oncolytics announces highlights from KOL on pelareorep data
3d ago
ONCY
Oncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025
PremiumCompany Announcements
Oncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025
4d ago
6K
ONCY
Oncolytics regains Nasdaq compliance
PremiumThe Fly
Oncolytics regains Nasdaq compliance
4d ago
ONCY
Oncolytics Biotech Unveils Promising Data on Pelareorep’s Efficacy Across Tumor Types
PremiumCompany AnnouncementsOncolytics Biotech Unveils Promising Data on Pelareorep’s Efficacy Across Tumor Types
10d ago
ONCY
Oncolytics reports data from pelareorep studies
Premium
The Fly
Oncolytics reports data from pelareorep studies
10d ago
ONCY
Oncolytics Biotech to Host Webinar on Pelareorep’s Potential in Cancer Treatment
Premium
Company Announcements
Oncolytics Biotech to Host Webinar on Pelareorep’s Potential in Cancer Treatment
16d ago
6K
ONCY
Oncolytics Biotech’s Strategic Advancements and Leadership Changes Drive Buy Rating
PremiumRatings
Oncolytics Biotech’s Strategic Advancements and Leadership Changes Drive Buy Rating
17d ago
ONCY
Oncolytics Biotech Highlights Promising Pelareorep Data in Cancer Treatment
PremiumCompany Announcements
Oncolytics Biotech Highlights Promising Pelareorep Data in Cancer Treatment
18d ago
ONCY
Oncolytics Biotech Appoints New Chief Business Officer to Enhance Business Strategy
PremiumCompany Announcements
Oncolytics Biotech Appoints New Chief Business Officer to Enhance Business Strategy
26d ago
ONCY
Oncolytics names Andrew Aromando as Chief Business Officer
PremiumThe Fly
Oncolytics names Andrew Aromando as Chief Business Officer
26d ago
ONCY
Oncolytics Biotech Appoints New CEO to Drive Immunotherapy Advancements
PremiumCompany AnnouncementsOncolytics Biotech Appoints New CEO to Drive Immunotherapy Advancements
1M ago
ONCY
Oncolytics names Jared Kelly as CEO
Premium
The Fly
Oncolytics names Jared Kelly as CEO
1M ago
ONCY
Oncolytics Biotech Unveils Promising Pelareorep Data at ASCO 2025
Premium
Company Announcements
Oncolytics Biotech Unveils Promising Pelareorep Data at ASCO 2025
2M ago
ONCY
Oncolytics presents new data from Phase I/II GOBLET clinical trial
PremiumThe Fly
Oncolytics presents new data from Phase I/II GOBLET clinical trial
2M ago
ONCY
Promising Clinical Developments and Strategic Advancements Justify Buy Rating for Oncolytics Biotech
PremiumRatings
Promising Clinical Developments and Strategic Advancements Justify Buy Rating for Oncolytics Biotech
2M ago
ONCY
Oncolytics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Oncolytics downgraded to Hold from Buy at JonesResearch
2M ago
ONCY
Oncolytics Biotech’s Strategic Advances in Oncology: Promising Developments in Breast and Pancreatic Cancer Research
PremiumRatings
Oncolytics Biotech’s Strategic Advances in Oncology: Promising Developments in Breast and Pancreatic Cancer Research
2M ago
ONCY
Oncolytics Biotech’s Earnings Call: Optimism Amid Challenges
PremiumCompany AnnouncementsOncolytics Biotech’s Earnings Call: Optimism Amid Challenges
2M ago
ONCY
Oncolytics Biotech Reports Q1 Results and Clinical Progress
Premium
Company Announcements
Oncolytics Biotech Reports Q1 Results and Clinical Progress
2M ago
ONCY
Oncolytics Biotech Reports Q1 2025 Financial Results
Premium
Company Announcements
Oncolytics Biotech Reports Q1 2025 Financial Results
2M ago
6K
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >